These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25417119)

  • 21. Arterial Inflammation Detected With
    Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
    Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.
    Beckers C; Jeukens X; Ribbens C; André B; Marcelis S; Leclercq P; Kaiser MJ; Foidart J; Hustinx R; Malaise MG
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):275-80. PubMed ID: 16247604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
    Tachibana M; Yonemoto Y; Okamura K; Suto T; Sakane H; Kaneko T; Dam TT; Okura C; Tajika T; Tsushima Y; Chikuda H
    Arthritis Res Ther; 2020 Jul; 22(1):178. PubMed ID: 32711580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
    Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH
    Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
    Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
    Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
    Amigues I; Tugcu A; Russo C; Giles JT; Morgenstein R; Zartoshti A; Schulze C; Flores R; Bokhari S; Bathon JM
    Arthritis Rheumatol; 2019 Apr; 71(4):496-506. PubMed ID: 30407745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.
    Kubota K; Ito K; Morooka M; Minamimoto R; Miyata Y; Yamashita H; Takahashi Y; Mimori A
    Ann N Y Acad Sci; 2011 Jun; 1228():29-38. PubMed ID: 21718320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index.
    Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Yamasaki S; Nakamura H; Ueki Y; Migita K; Mizokami A; Origuchi T; Aoyagi K; Eguchi K
    Mod Rheumatol; 2011 Aug; 21(4):365-9. PubMed ID: 21229375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
    Kawashiri SY; Nishino A; Suzuki T; Nakashima Y; Horai Y; Ueki Y; Aramaki T; Fujikawa K; Nakashima M; Okada A; Migita K; Mizokami A; Matsuoka N; Mine M; Sakito S; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Aoyagi K; Eguchi K; Kawakami A
    Clin Exp Rheumatol; 2016; 34(5):808-812. PubMed ID: 27384149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
    Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.
    Elzinga EH; van der Laken CJ; Comans EF; Lammertsma AA; Dijkmans BA; Voskuyl AE
    Mol Imaging Biol; 2007; 9(6):357-60. PubMed ID: 17902022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
    Raynor WY; Jonnakuti VS; Zirakchian Zadeh M; Werner TJ; Cheng G; Zhuang H; Høilund-Carlsen PF; Alavi A; Baker JF
    Int J Rheum Dis; 2019 Dec; 22(12):2191-2198. PubMed ID: 31721461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.
    Roivainen A; Hautaniemi S; Möttönen T; Nuutila P; Oikonen V; Parkkola R; Pricop L; Ress R; Seneca N; Seppänen M; Yli-Kerttula T
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):403-10. PubMed ID: 23229747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study.
    Elzinga EH; van der Laken CJ; Comans EF; Boellaard R; Hoekstra OS; Dijkmans BA; Lammertsma AA; Voskuyl AE
    J Nucl Med; 2011 Jan; 52(1):77-80. PubMed ID: 21149486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
    Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
    Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
    Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
    Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.